Literature DB >> 24894166

KiSS1-induced GPR54 signaling inhibits breast cancer cell migration and epithelial-mesenchymal transition via protein kinase D1.

K Tan, S-G Cho, W Luo, T Yi, X Wu, S Siwko, M Liu, W Yuan1.   

Abstract

The metastasis suppressor protein Kisspeptin regulates cancer cell proliferation and motility through its receptor, GRP54. However, the critical downstream effectors remain unclear. In this study, we investigated GPR54 signaling in breast cancer cells. Kisspeptin stimulation caused a decrease in migration of multiple breast cancer cell lines. Also, Kisspeptin inhibited MDA-MB-231 cell colony formation in 3D matrigel culture and in soft agar. Kisspeptin treatment elevated phosphorylated PKD1 in a PKC-dependent manner. However, knockdown of either GPR54 or PKD1 increased breast cancer cell migration and invasion. Furthermore, GPR54 knockdown blocked Kisspeptin-induced phosphorylation of PKD1. Finally, Kisspeptin stimulation induced a PKD1 phosphorylation-dependent decrease in expression of Slug, a transcription factor that drives epithelial-mesenchymal transition (EMT), and a concomitant increase in E-cadherin expression. Therefore, KiSS1/GPR54 signaling through PKD1 acts to maintain the epithelial state and to inhibit breast cancer cell invasiveness, and exerts functions associated with its role as a metastasis suppressor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24894166     DOI: 10.2174/1566524014666140603115314

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  8 in total

1.  Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.

Authors:  Michelle R Roberts; Lara E Sucheston-Campbell; Gary R Zirpoli; Michael Higgins; Jo L Freudenheim; Elisa V Bandera; Christine B Ambrosone; Song Yao
Journal:  Mol Carcinog       Date:  2016-09-21       Impact factor: 4.784

Review 2.  KISS1 in metastatic cancer research and treatment: potential and paradoxes.

Authors:  Thuc Ly; Sitaram Harihar; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 3.  Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1.

Authors:  Sitaram Harihar; Srijit Ray; Samyukta Narayanan; Anirudh Santhoshkumar; Thuc Ly; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2020-02-22       Impact factor: 5.150

Review 4.  The Network of Cytokines in Brain Metastases.

Authors:  Jawad Fares; Alex Cordero; Deepak Kanojia; Maciej S Lesniak
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

5.  Kisspeptin Activates Ankrd 26 Gene Expression in Migrating Embryonic GnRH Neurons.

Authors:  Tomoko Soga; Wei Ling Lim; Alan Soo-Beng Khoo; Ishwar S Parhar
Journal:  Front Endocrinol (Lausanne)       Date:  2016-03-01       Impact factor: 5.555

6.  Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.

Authors:  Zhan-Long Shen; Bo Wang; Ke-Wei Jiang; Chun-Xiang Ye; Cheng Cheng; Yi-Chao Yan; Ji-Zhun Zhang; Yang Yang; Zhi-Dong Gao; Ying-Jiang Ye; Shan Wang
Journal:  Oncotarget       Date:  2016-06-07

7.  Functional examination of novel kisspeptin phosphinic peptides.

Authors:  Xiaoyang Zhang; Magdalini Matziari; Yixin Xie; David Fernig; Rong Rong; Jia Meng; Zhi-Liang Lu
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

8.  Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.

Authors:  Yue Chen; Cheng Zhang; Jing Chen; Bohan Zhang; Hongqi Zhang; Xuetao Yang; Jingshu Liu; Qingchen Wu
Journal:  Med Sci Monit       Date:  2018-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.